| Phase III randomized trial comparing three platinum-based doublets in advanced non-small-cell lung cancer GV Scagliotti, F De Marinis, M Rinaldi, L Crino, C Gridelli, S Ricci, ... Journal of clinical oncology 20 (21), 4285-4291, 2002 | 1223 | 2002 |
| Chemotherapy for elderly patients with advanced non-small-cell lung cancer: the Multicenter Italian Lung Cancer in the Elderly Study (MILES) phase III randomized trial C Gridelli, F Perrone, C Gallo, S Cigolari, A Rossi, F Piantedosi, ... Journal of the National Cancer Institute 95 (5), 362-372, 2003 | 1070 | 2003 |
| Randomized study of adjuvant chemotherapy for completely resected stage I, II, or IIIA non–small-cell lung cancer GV Scagliotti, R Fossati, V Torri, L Crino, G Giaccone, G Silvano, ... Journal of the National Cancer Institute 95 (19), 1453-1461, 2003 | 816 | 2003 |
| Randomized phase III trial comparing biweekly infusional fluorouracil/leucovorin alone or with irinotecan in the adjuvant treatment of stage III colon cancer: PETACC-3 E Van Cutsem, R Labianca, G Bodoky, C Barone, E Aranda, B Nordlinger, ... J Clin Oncol 27 (19), 3117-3125, 2009 | 606 | 2009 |
| Pretreatment quality of life and functional status assessment significantly predict survival of elderly patients with advanced non-small-cell lung cancer receiving chemotherapy … P Maione, F Perrone, C Gallo, L Manzione, FV Piantedosi, S Barbera, ... Journal of Clinical Oncology 23, 6865-6872, 2005 | 564 | 2005 |
| Clinical determinants of survival in patients with 5-fluorouracil-based treatment for metastatic colorectal cancer: results of a multivariate analysis of 3825 patients CH Köhne, D Cunningham, F Di Costanzo, B Glimelius, G Blijham, ... Annals of Oncology 13 (2), 308-317, 2002 | 564 | 2002 |
| Gemcitabine alone or with cisplatin for the treatment of patients with locally advanced and/or metastatic pancreatic carcinoma: A prospective, randomized phase III study of the … G Colucci, F Giuliani, V Gebbia, M Biglietto, P Rabitti, G Uomo, S Cigolari, ... Cancer 94 (4), 902-910, 2002 | 555 | 2002 |
| Gemcitabine and cisplatin versus mitomycin, ifosfamide, and cisplatin in advanced non–small-cell lung cancer: A randomized phase III study of the Italian Lung Cancer Project L Crino, GV Scagliotti, S Ricci, F De Marinis, M Rinaldi, C Gridelli, ... Journal of Clinical Oncology 17 (11), 3522-3530, 1999 | 461 | 1999 |
| Randomized phase III trial of gemcitabine plus cisplatin compared with single-agent gemcitabine as first-line treatment of patients with advanced pancreatic cancer: the GIP-1 … G Colucci, R Labianca, F Di Costanzo, V Gebbia, G Cartenì, B Massidda, ... | 378 | 2010 |
| Front‐line chemotherapy with cisplatin and etoposide for patients with brain metastases from breast carcinoma, nonsmall cell lung carcinoma, or malignant melanoma: a … V Franciosi, G Cocconi, M Michiara, F Di Costanzo, V Fosser, M Tonato, ... Cancer: Interdisciplinary International Journal of the American Cancer …, 1999 | 315 | 1999 |
| Efficacy of 5-fluorouracil-based chemotherapy in elderly patients with metastatic colorectal cancer: a pooled analysis of clinical trials G Folprecht, D Cunningham, P Ross, B Glimelius, F Di Costanzo, J Wils, ... Annals of Oncology 15 (9), 1330-1338, 2004 | 302 | 2004 |
| Chemotherapy-induced neutropenia and treatment efficacy in advanced non-small-cell lung cancer: a pooled analysis of three randomised trials M Di Maio, C Gridelli, C Gallo, F Shepherd, FV Piantedosi, S Cigolari, ... The lancet oncology 6 (9), 669-677, 2005 | 293 | 2005 |
| Upfront FOLFOXIRI plus bevacizumab and reintroduction after progression versus mFOLFOX6 plus bevacizumab followed by FOLFIRI plus bevacizumab in the treatment of patients with … C Cremolini, C Antoniotti, D Rossini, S Lonardi, F Loupakis, F Pietrantonio, ... The Lancet Oncology 21 (4), 497-507, 2020 | 255 | 2020 |
| Randomized trial of intravenous iron supplementation in patients with chemotherapy-related anemia without iron deficiency treated with darbepoetin alfa P Pedrazzoli, A Farris, S Del Prete, F Del Gaizo, D Ferrari, C Bianchessi, ... Journal of Clinical Oncology 26 (10), 1619-1625, 2008 | 236 | 2008 |
| Ramucirumab with cisplatin and fluoropyrimidine as first-line therapy in patients with metastatic gastric or junctional adenocarcinoma (RAINFALL): a double-blind, randomised … CS Fuchs, K Shitara, M Di Bartolomeo, S Lonardi, SE Al-Batran, ... The Lancet Oncology 20 (3), 420-435, 2019 | 227 | 2019 |
| Continuation or reintroduction of bevacizumab beyond progression to first-line therapy in metastatic colorectal cancer: final results of the randomized BEBYP trial G Masi, L Salvatore, L Boni, F Loupakis, C Cremolini, L Fornaro, ... Annals of Oncology 26 (4), 724-730, 2015 | 191 | 2015 |
| Cetuximab plus gemcitabine and cisplatin compared with gemcitabine and cisplatin alone in patients with advanced pancreatic cancer: a randomised, multicentre, phase II trial S Cascinu, R Berardi, R Labianca, S Siena, A Falcone, E Aitini, S Barni, ... The lancet oncology 9 (1), 39-44, 2008 | 175 | 2008 |
| CheckMate 040 cohort 5: a phase I/II study of nivolumab in patients with advanced hepatocellular carcinoma and Child-Pugh B cirrhosis M Kudo, A Matilla, A Santoro, I Melero, AC Gracián, M Acosta-Rivera, ... Journal of hepatology 75 (3), 600-609, 2021 | 155 | 2021 |
| Adjuvant chemotherapy in completely resected gastric cancer: a randomized phase III trial conducted by GOIRC F Di Costanzo, S Gasperoni, L Manzione, G Bisagni, R Labianca, S Bravi, ... Journal of the National Cancer Institute 100 (6), 388-398, 2008 | 150 | 2008 |
| Fluorouracil, doxorubicin, and mitomycin combination versus PELF chemotherapy in advanced gastric cancer: a prospective randomized trial of the Italian Oncology Group for … G Cocconi, M Bella, S Zironi, R Algeri, F Di Costanzo, V De Lisi, G Luppi, ... Journal of clinical oncology 12 (12), 2687-2693, 1994 | 138 | 1994 |
Luca BoniIRCCS Ospedale Policlinico San MartinoEmail verificata su hsanmartino.it
